Oral anticoagulants in coronary heart disease (Section IV): Position paper of the ESC working group on thrombosis – Task force on anticoagulants in heart disease

Oral anticoagulants in coronary heart disease (Section IV): Position paper of the ESC working group on thrombosis – Task force on anticoagulants in heart disease / De Caterina, R; Husted, S; Wallentin, L; Andreotti, F; Arnesen, H; Bachmann, F; Baigent, C; Collet, J-P; Halvorsen, S; Huber, K; Jespersen, J; Kristensen, Sd; Lip, Gyh; Morais, J; Rasmussen, Lh; Ricci, F; Sibbing, D; Siegbahn, A; Storey, Rf; ten Berg, J; Verheugt, Fwa; Weitz, Ji. - In: THROMBOSIS AND HAEMOSTASIS. - ISSN 0340-6245. - 115(2016), pp. 685-711.



Autori interni: 
DE CATERINA, RAFFAELE
mostra contributor esterni 
Autori: De Caterina, R; Husted, S; Wallentin, L; Andreotti, F; Arnesen, H; Bachmann, F; Baigent, C; Collet, J-P; Halvorsen, S; Huber, K; Jespersen, J; Kristensen, Sd; Lip, Gyh; Morais, J; Rasmussen, Lh; Ricci, F; Sibbing, D; Siegbahn, A; Storey, Rf; ten Berg, J; Verheugt, Fwa; Weitz, Ji
Titolo: Oral anticoagulants in coronary heart disease (Section IV): Position paper of the ESC working group on thrombosis – Task force on anticoagulants in heart disease
Anno del prodotto: 2016
Digital Object Identifier (DOI): 10.1160/TH15-09-0703
Appare nelle tipologie:1.1 Articolo in rivista

File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2020